ACM
SYRS

Adalta Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Adalta Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,593
Closed -$190K – 80
2018
Q3 		$190K Hold
1,593
– – 0.14% 75
2018
Q2 		$163K Buy
1,593
+78
+5% +$7.98K 0.12% 77
2018
Q1 		$197K Buy
1,515
+377
+33% +$49K 0.15% 70
2017
Q4 		$111K Buy
+1,138
New +$111K 0.08% 71